Loading clinical trials...
Loading clinical trials...
A single rising dose study to assess the safety, tolerability, pharmacokinetics and pharmacodynamics of MK-1006 in Japanese participants with Type 2 Diabetes Mellitus (T2DM). The primary hypothesis of...
Keep your clinical trial research organized — questions to ask, what to expect, and key details.
Lead Sponsor
Merck Sharp & Dohme LLC
NCT02088658 · Diabetes Mellitus, Type 2, Diabetes Mellitus, Adult-Onset, and more
NCT02113163 · Diabetes Mellitus, Non-Insulin-Dependent, Hypertriglyceridemia
NCT00004992 · Diabetes Mellitus, Non-Insulin-Dependent, Glucose Intolerance
NCT02541734 · Diabetes Mellitus, Non-Insulin-Dependent, Diabetes Mellitus
NCT00875394 · Diabetes Mellitus, Non-Insulin-Dependent
Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.
Start free trial →Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions